DAWN vs K · rev $131.2M vs P/E 23, $29.03B cap
Day One Biopharmaceuticals Inc (DAWN) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
K does not have a complete income-statement cache yet.
DAWN currently screens at market cap $656.8M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the DAWN and K stock pages for the full models.
Not investment advice.